ILF3-DT: A Potential Drug Target and Biomarker for Neurological Disorders

Target Name: ILF3-DT

NCBI ID: G147727

ILF3-DT

Other Name(s): ILF3 divergent transcript | ILF3-AS1

ILF3-DT: A Potential Drug Target and Biomarker for Neurological Disorders

The International Ludbach Society (ILF3) is a protein of importance in the fields of neuroscience and psychology. ILF3 plays a key role in regulating synaptic plasticity and cell proliferation. There are differences in the gene coding sequences of the three main splice variants of ILF3 (ILF3-DT, ILF3-IT, ILF3-CT), among which the protein encoded by the ILF3-DT gene has been shown to play an important role in neuronal synaptic plasticity and cognitive function. effect. This article aims to explore the research value of ILF3-DT as a drug target or biomarker.

The function and structure of ILF3-DT

ILF3 is a transcription factor involved in regulating neuronal cell cycle, proliferation and apoptosis. There are differences in the gene coding sequences of the three splice variants of ILF3 (ILF3-DT, ILF3-IT, ILF3-CT). These differences are mainly reflected in the differences in exon number and sequence. The protein encoded by the ILF3-DT gene contains a conserved N-terminal 伪-helix, a central 尾-page, and a C-terminal domain. Compared with other splice variants, the protein encoded by the ILF3-DT gene is highly conserved in terms of amino acid sequence and domain, which indicates that ILF3-DT plays an important role in neuronal synaptic plasticity and cell proliferation.

Bioactivity analysis

To determine the function of ILF3-DT in terms of biological activity, the researchers conducted a biological activity analysis of the protein encoded by the ILF3-DT gene. Bioactivity analysis can detect the ability of a protein to bind to a specific ligand and the level of protein activity in an organism. Through biological activity analysis, the researchers found that the protein encoded by the ILF3-DT gene can specifically bind to proteins related to neuronal synaptic plasticity and cell proliferation, which indicates that ILF3-DT plays an important role in biological activity.

Drug target research

Drugs have broad application prospects in the treatment of neurological diseases. The important role of ILF3-DT in neuronal synaptic plasticity and cell proliferation makes it a hot topic in drug target research. Currently, researchers are exploring pharmacological intervention targeting ILF3-DT to treat neurological diseases.

biomarker research

Biomarkers refer to biological molecules that can be used for disease diagnosis and treatment monitoring. The important role of ILF3-DT in neuronal synaptic plasticity and cell proliferation processes makes it a potential biomarker. Currently, researchers are exploring the use of ILF3-DT as a biomarker of neuronal synaptic plasticity and cell proliferation for diagnosis and treatment.

in conclusion

The protein encoded by the ILF3-DT gene plays an important role in neuronal synaptic plasticity and cell proliferation. Bioactivity analysis showed that ILF3-DT has the specific binding ability to proteins related to neuronal synaptic plasticity and cell proliferation. Drug target research and biomarker research provide a theoretical basis for revealing the application prospects of ILF3-DT in the treatment of neurological diseases. With the continuous advancement of technology, it is expected that drug intervention and biomarker detection targeting ILF3-DT will bring revolutionary changes to the treatment of neurological diseases in the future.

Protein Name: ILF3 Divergent Transcript

The "ILF3-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ILF3-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets